February 2nd 2016: Introduction to XBiotech and their Novel True Human'TM' Approach |eCard

TROUBLE VIEWING? Click Here to view the Promo card on the web

SIGN-UP NOW! Click to become a Member for Free!

C. diff. Spores and More

Tuesday at 10 AM Pacific

February 2nd 2016: Introduction to XBiotech and their Novel True Human'TM' Approach

This episode introduces XBiotech, developer of True Human(TM) therapeutic antibodies. XBiotech has an exciting pipeline of product candidates in various areas of medicine. The Company recently announced the launch of a research and development program to develop a first-in-class oral monoclonal antibody against Clostridium difficile (C.difficile) infection. The Company will discuss the need for an effective C.difficile therapy, their novel approach to treating the disease as well as efficiency in their manufacturing technology. Join guests: Dr. Michael Stecher, Medical Director, Dr. Sushma Sh

Read more

DOWNLOAD PDF

Tune in

Tuesday at 10 AM Pacific Time on VoiceAmerica Health and Wellness Channel

LISTEN LIVE

EPISODE ON DEMAND

VIEW HOST PAGE

Questions? Comments?
Call In Live! Call-In
Toll Free: 1-866-472-5792
Intl: 001-480-553-5759

Featured Guests

Dr Michael Stecher MD

Dr Michael Stecher is the Medical Director of XBiotech. Dr. Stecher has served as Medical Director since June 2010 and has worked to develop XBiotech's Clinical Program to treat Chronic Inflammatory Disease through targeting the interleukin-1 system, collaborating with key opinion leaders in fields of Endocrinology, Oncology, Cardiovascular medicine, and Dermatology. Dr. Stecher is Board Certified in Family Medicine and a graduate from the University of Kansas School of Medicine.

Read more

Dr Sushma Shivaswamy, PhD

Dr Sushma Shivaswamy, Vice President of Research and Development; Dr. Shivaswamy joined XBiotech in May 2009 as a Senior Research Scientist and quickly advanced to lead the R&D group as Director of Research. Dr. Shivaswamy's academic studies involved elucidating mechanisms for regulation of gene expression. Prior to joining XBiotech, Dr. Shivaswamy was a postdoctoral researcher a the Center for Systems and Synthetic Biology at the University of Texas of Austin.

Read more

Kelly Thornburg

Mr. Thornburg joined XBiotech as Senior Vice President of Operations in June 2015. In this capacity Mr.Thornburg will be responsible for Manufacturing & Quality functions. Prior to joining XBiotech, Mr. Thornburg worked at Amgen, Inc. for sixteen years, most recently serving as the Executive Director Quality Site Head at the Amgen Colorado manufacturing site.

Read more

Share This Episode

Share On Facebook

Share On Twitter

Share On LinkedIn

Connect with VoiceAmerica

Download our mobile apps